---
schema_version: "secwatch.filing_event.v1"
accession: "0001079973-22-001114"
form_type: "8-K"
ticker: "CDIO"
cik: "0001870144"
company_name: "Cardio Diagnostics Holdings, Inc."
filed_at: "2022-09-15T23:59:59+00:00"
generated_at: "2026-06-23T09:30:38.618195+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Mana Capital and Cardio Diagnostics Amend Merger Agreement to Increase Incentive Plan Shares and Provide Equity to UIRF

## Summary
- Amendment dated September 15, 2022 increases shares reserved under Cardio Diagnostics Holdings 2022 Incentive Plan to 3,265,516.
- Upon closing, University of Iowa Research Foundation to receive 1% of aggregate merger consideration as common stock of Mana Capital.
- Amendment modifies treatment of Company Equity Rights and adjusts Exchange Ratio definition in the Merger Agreement.
- Other terms of the original Merger Agreement dated May 27, 2022 remain in full force and effect.
- Business combination still subject to stockholder approval and customary closing conditions.

## SEC filing metadata
- accession: 0001079973-22-001114
- form_type: 8-K
- ticker: CDIO
- cik: 0001870144
- company_name: Cardio Diagnostics Holdings, Inc.
- filed_at: 2022-09-15T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1870144/000107997322001114/0001079973-22-001114-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1870144/000107997322001114/mana_8k-091522.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001079973-22-001114
- JSON: https://secwatch.observer/filing/0001079973-22-001114.json
- Plain text: https://secwatch.observer/filing/0001079973-22-001114.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.